Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 33 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study To Assess Adverse Events Of Intravenously (IV) Infused ABBV-383 In Adult Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. KTX-100 MMSET Catalytic Inhibitor That Suppresses H3K36me2 In Patients With Relapsed And Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory Multiple Myeloma And Immunoglobulin Light Chain Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma

    Rochester, MN, La Crosse, WI

  5. A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA)

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  6. Comparing Combinations Of Drugs To Treat Newly Diagnosed Multiple Myeloma (NDMM) When A Stem Cell Transplant Is Not A Medically Suitable Treatment

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. American Society of Hematology Research Collaborative’s Data Hub Multiple Myeloma Program

    Rochester, MN

  8. Impact Of Restricted Medication Access On Care Of Multiple Myeloma Patients

    Rochester, MN

  9. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  10. Development Of A Normal Hematologic Resource For The Aging Mechanisms In Myeloma, Amyloid, And Dysproteinemia Diseases

    Rochester, MN

.

Mayo Clinic Footer